Filing Flows › Innospec (IOSP) › R&D spending
Innospec (IOSP) R&D spending by quarter
Innospec's R&D spending was $14.2M in Q2 2026 (second quarter 2026), +29% from Q4 2025. Over the last 5 quarters it ranged from $11.0M (Q4 2025) to $14.2M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $14.2M | +29% | +4% |
| Q4 2025 | $11.0M | -20% | — |
| Q3 2025 | $13.7M | +0.7% | — |
| Q2 2025 | $13.6M | +7% | — |
| Q1 2025 | $12.7M | — | — |
Q2 2026 at a glance
Innospec, Q2 2026: revenue $491M (+12% year over year), operating margin 8.1%, net earnings $31.2M, operating cash flow $7.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innospec's R&D spending?
Innospec's R&D spending was $14.2M in Q2 2026 (second quarter 2026), +29% from Q4 2025.
How has Innospec's R&D spending changed?
Over the last 5 quarters it ranged from $11.0M (Q4 2025) to $14.2M (Q2 2026).